Cleared Traditional

K181527 - On Call Sure Blood Glucose Monitoring S...

K181527 is the FDA 510(k) clearance for On Call Sure Blood Glucose Monitoring S... by ACON Laboratories, Inc.. It is a Class 2 Chemistry device (product code NBW) cleared through the Traditional 510(k) pathway after a 114-day FDA review.

K181527 · ACON Laboratories, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2018
Decision
114d
Days
Class 2
Risk

K181527 is an FDA 510(k) clearance for the On Call Sure Blood Glucose Monitoring System, On Call Sure Sync Blood Glucose.... Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by ACON Laboratories, Inc. (San Diego, US). The FDA issued a Cleared decision on October 3, 2018 after a review of 114 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all ACON Laboratories, Inc. devices

Submission Details

510(k) Number K181527 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 11, 2018
Decision Date October 03, 2018
Days to Decision 114 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
26d slower than avg
Panel avg: 88d · This submission: 114d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 235
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K181527.
Tyson Bio HT100-A Blood Glucose Monitoring System
K182047 · Tyson Bioresearch, Inc. · Nov 2018
BGM014 Blood Glucose Monitoring System
K182992 · Apex BioTechnology Corp. · Nov 2018
GLUCOCARD Shine Connex Blood Glucose Monitoring System, GLUCOCARD Shine Express Blood Glucose Monitoring System
K181273 · I-Sens, Inc. · Nov 2018
Oh'Care Lite Smart Blood Glucose Monitoring System
K182286 · Osang Healthcare Co. , Ltd. · Sep 2018
CareSens S Fit Blood Glucose Monitoring System
K180866 · I-Sens, Inc. · Aug 2018
EasyMax BT Self-Monitoring Blood Glucose System
K182057 · Eps Bio Technology Corp. · Aug 2018